Cerulein-induced pancreatic fibrosis is modulated by Smad7, the major negative regulator of transforming growth factor-β signaling.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2016-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbadis.2016.06.017PMID 27349482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling*

  2015cited by this paper
• Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.

  2015cited by this paper
• Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis

  2015cited by this paper
• Models of acute and chronic pancreatitis.

  2013cited by this paper
• Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs

  2013cited by this paper
• Disruption of Smad7 Promotes ANG II-Mediated Renal Inflammation and Fibrosis via Sp1-TGF-β/Smad3-NF.κB-Dependent Mechanisms in Mice

  2013cited by this paper
• Pancreatic stellate cells: a starring role in normal and diseased pancreas

  2012cited by this paper
• TGFβ signalling in context

  2012cited by this paper
• RNF12 controls embryonic stem cell fate and morphogenesis in zebrafish embryos by targeting Smad7 for degradation.

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012cited by this paper
• StellaTUM: current consensus and discussion on pancreatic stellate cell research

  2011cited by this paper
• Animal models for investigating chronic pancreatitis

  2011cited by this paper
• The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential

  2011cited by this paper
• Role of Smads in TGFβ signaling

  2011cited by this paper
• Hepatic Deletion of Smad7 in Mouse Leads to Spontaneous Liver Dysfunction and Aggravates Alcoholic Liver Injury

  2011cited by this paper
• TGF-β signaling in fibrosis

  2011cited by this paper
• Protection Against Chronic Pancreatitis and Pancreatic Fibrosis in Mice Overexpressing Pancreatic Secretory Trypsin Inhibitor

  2010cited by this paper
• Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.

  2009cited by this paper
• Protection of cerulein-induced pancreatic fibrosis by pancreas-specific expression of Smad7.

  2009cited by this paper
• Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice

  2008cited by this paper
• Smad7 Antagonizes Transforming Growth Factor β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation

  2007cited by this paper
• The pancreatic stellate cell: a star on the rise in pancreatic diseases.

  2007cited by this paper
• SMAD7: at the interface of TGF-beta and proinflammatory signaling.

  2007cited by this paper
• SMAD7: At the Interface of TGF-β and Proinflammatory Signaling

  2007cited by this paper
• In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas.

  2006cited by this paper
• Deletion of Exon I of SMAD7 in Mice Results in Altered B Cell Responses

  2006cited by this paper
• Conditional Expression of Smad7 in Pancreatic β Cells Disrupts TGF-β Signaling and Induces Reversible Diabetes Mellitus

  2006cited by this paper
• Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.

  2005cited by this paper
• NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.

  2005cited by this paper
• NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor

  2005cited by this paper
• Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.

  2004cited by this paper
• Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.

  2003cited by this paper
• Arkadia amplifies TGF‐β superfamily signalling through degradation of Smad7

  2003cited by this paper
• Human pancreatic acinar cells do not respond to cholecystokinin.

  2002cited by this paper
• Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation*

  2001cited by this paper
• Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.

  2000cited by this paper
• Repetitive Self-Limited Acute Pancreatitis Induces Pancreatic Fibrogenesis in the Mouse

  2000cited by this paper
• Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

  1999cited by this paper
• Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway

  1999cited by this paper
• Smad6 inhibits signalling by the TGF-beta superfamily.

  1997cited by this paper
• Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride.

  1997cited by this paper
• Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

  1997cited by this paper
• Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling.

  1997cited by this paper
• Smad6 inhibits signalling by the TGF-β superfamily

  1997cited by this paper
• Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice.

  1996cited by this paper
• QUANTITATIVE STUDY ON THE PRODUCTION AND KINETICS OF MONONUCLEAR PHAGOCYTES DURING AN ACUTE INFLAMMATORY REACTION

  1973cited by this paper

• Therapeutic potential of traditional Chinese medicine in pancreatic fibrosis: mechanisms of TCM formulas and active ingredients

  2025cites this paper
• Effect of histone deacetylases on pancreatic physiology and pathology: a review.

  2025cites this paper
• Systemic sclerosis and AHR: Shedding light on a hidden connections.

  2025cites this paper
• The TGF-β superfamily as potential therapeutic targets in pancreatic cancer

  2024cites this paper
• Candidate circulating microRNA biomarkers in dogs with chronic pancreatitis

  2024cites this paper
• Deletion of Smad7 Ameliorates Intestinal Inflammation and Contributes to Fibrosis.

  2022cites this paper
• Targeting of Smad7 in Mesenchymal Cells Does Not Exacerbate Fibrosis During Experimental Chronic Pancreatitis

  2021cites this paper
• High Cancer Susceptibility Candidate 8 Expression Is Associated With Poor Prognosis of Pancreatic Adenocarcinoma: Validated Analysis Based on Four Cancer Databases

  2020cites this paper
• Prospect and clinical value of oxymatrine in prevention and treatment of pancreatic fibrosis

  2020cites this paper
• Multimodal Imaging of Pancreatic Ductal Adenocarcinoma Using Multifunctional Nanoparticles as Contrast Agents

  2020cites this paper
• Current perspectives on inhibitory SMAD7 in health and disease

  2020cites this paper
• Tamoxifen affects chronic pancreatitis‐related fibrogenesis in an experimental mouse model: an effect beyond Cre recombination

  2019cites this paper
• Inhibition of class I histone deacetylases abrogates TGF expression and development of fibrosis during chronic pancreatitis

  2018cites this paper
• Inhibition of Class I Histone Deacetylases Abrogates Tumor Growth Factor β Expression and Development of Fibrosis during Chronic Pancreatitis

  2018cites this paper
• Genetically induced vs. classical animal models of chronic pancreatitis: a critical comparison

  2018cites this paper
• Elucidating the role of SMAD7 in pancreatic cancer through in vivo studies

  2017cites this paper